AMGN Amgen Inc. | US0311621009
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 38.689.934.970 | 37.756.137.430 | 2.47% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 23,46 | 22,34 | 5.01% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 31 | 33 | 6.06% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |